Corcept Therapeutics reported $17.07M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
Ani Pharmaceuticals ANIP:US USD 95.89M 3.35M
Ardelyx ARDX:US USD 1.25M 3.28M
Aurora Cannabis Inc ACB:CN CAD 146.24M 6.32M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Canopy Growth Corp WEED:CN CAD 211.21M 5.7M
Corcept Therapeutics CORT:US USD 17.07M 342K
Depomed DEPO:US USD 14.27M 2.01M
Esperion Therapeutics ESPR:US USD 29.54M 313K
Knight Therapeutics Inc GUD:CN CAD 84.94M 8.54M
Lannett LCI:US USD 94.78M 658K
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Novartis NOVN:VX USD 6.78B 101M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Supernus Pharmaceuticals SUPN:US USD 83.16M 1.69M